{"nct_id":"NCT04686305","title":"Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2021-03-09","start_date_type":"ACTUAL","primary_completion_date":"2027-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06-30","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AZN"]}